SCHEMBL6984846

SCHEMBL6984846

CCCCCCCCOC(=O)c1ccc(CCC(=O)N2CCCc3cc(N(CC(=O)OCC)S(=O)(=O)c4ccccc4)ccc32)c(C(=N)N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.38
MAPK1 P28482 2/20 0.38
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
LMNA P02545 3/20 0.36
HPGD P15428 2/20 0.36
HTT P42858 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRB3 P13945 2/20 0.36
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979175 0.91 USP2 (0.39) USP2MAPK1PDK1PDK2PDK3
SCHEMBL6981560 0.90 PDK1 (0.37) MAPTTP53SMN1; SMN2PDK1PDK2
SCHEMBL6984189 0.88 F2 (0.39) MAPK1MAPTTP53SMN1; SMN2PDK1
SCHEMBL6978636 0.85 PDK1 (0.36) USP2MAPTTP53SMN1; SMN2PDK1
SCHEMBL6985778 0.83 NR3C1 (0.43) USP2MAPK1PDK1PDK2PDK3
SCHEMBL6984052 0.83 ADRB2 (0.48) MAPTTP53SMN1; SMN2LMNAHPGD
SCHEMBL6984844 0.83 USP2 (0.39) USP2MAPK1MAPTTP53SMN1; SMN2
SCHEMBL7089640 0.83 PDK1 (0.36) PDK1PDK2PDK3PDK4LMNA
SCHEMBL7960545 0.81 F2 (0.44) MAPTTP53SMN1; SMN2PDK1PDK2
SCHEMBL6980895 0.80 PDK1 (0.40) USP2MAPK1MAPTSMN1; SMN2PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed